Topiroxostat is a xanthine oxidoreductase (XOR) inhibitor and used for treatment of gout and hyperuricemia. Topiroxostat exhibits weak CYP3A4-inhibitory activity (18.6%). Topiroxostat has the potential for hyperuricemia treatment
Synonyms:
4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile;
4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-2-Pyridinecarbonitrile;
Topiroxostat
Properties:
Boiling point: 594.7±60.0 °C(Predicted)
density: 1.45±0.1 g/cm3(Predicted)
pka: 7.47±0.10(Predicted)
Xanthine Oxidase Related Products:
Allopurinol; Febuxostat